missing translation for 'onlineSavingsMsg'
Learn More
Learn More
PRDM9 Recombinant Rabbit Monoclonal Antibody (1H9Z1), Invitrogen™
Rabbit Recombinant Monoclonal Antibody
Brand: Thermo Scientific MA551196
This item is not returnable.
View return policy
Description
Immunogen sequence: DSEDSDEEWT PKQQVSPPWV PFRVKHSKQQ KESSRMPFSG ESNVKEGSGI ENLLNTSGSE HVQKPVSSLE EGNTSGQHSG KKLKLRKKNV EVKMYRLRER KGLAYEEVSE PQDDDYLYCE KCQNFFIDSC PNHGPPLFVK DSMVDRGHPN HSVLSLPPGL RISPSGIPEA GLGVWNEASD LPVGLHFGPY EGQITEDEEA ANSGYSWLIT KGRNCYEYVD GQDESQANWM RYVNCARDDE EQNLVAFQYH RKIFYRTCRV IRPGCELLVW YGDEYGQELG IKWG
PRDM9 Recombinant Monoclonal antibody specifically detects PRDM9 in Human, Mouse, Rat samples. It is validated for Immunohistochemistry (Paraffin), Western Blot
Specifications
PRDM9 | |
Recombinant Monoclonal | |
1 mg/mL | |
PBS with 0.05% BSA, 50% glycerol and 0.05% ProClin 300; pH 7.3 | |
P0C6Y7, Q96EQ9, Q9NQV7 | |
Rabbit | |
Affinity chromatography | |
RUO | |
213389, 365155, 56979 | |
-20° C, Avoid Freeze/Thaw Cycles | |
IgG |
Immunohistochemistry (Paraffin), Western Blot | |
1H9Z1 | |
Unconjugated | |
PRDM9 | |
Histone-lysine N-methyltransferase PRDM9, MEISETZ, minisatellite binding protein 3 (115kD), MSBP3, PFM6, PR domain 9, PR domain containing 7, PR domain containing 9, PR domain zinc finger protein 9, PR domain-containing protein 9, Prdm7, Prdm9, Protein-lysine N-methyltransferase PRDM9, ZNF899 | |
Recombinant fusion protein containing a sequence corresponding to amino acids 87-370 of mouse Prdm9 (NP_659058.3). | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Liquid |
Product Suggestions
Customers who viewed this item also viewed
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
PRDM9 Recombinant Rabbit Monoclonal Antibody (1H9Z1), Invitrogen™ > 100 μL, Unconjugated
Spot an opportunity for improvement?Share a Content Correction